Literature DB >> 9119284

The changing pattern of venous thromboembolic disease.

A T Cohen1, R A Edmondson, M J Phillips, V P Ward, V V Kakkar.   

Abstract

A review of 14,667 necropsy reports for every year from 1965 to 1990 and 6,436 diagnostic venograms performed from 1976 to 1990 was undertaken at a single teaching hospital. A progressive reduction in the percentage of necropsies reporting fatal pulmonary embolism from 6.1 to 2.1%, occurred over the 25-year period (chi(2) tests for linear trend with time p < 0.00001). Over the last decade, there has been a significant reduction in the rate of venographically diagnosed postoperative deep vein thrombosis (DVT) from 49.9 to 24.7 per 100,000 population (p < 0.0001) which was in marked contrast to the constant rate of non-postoperative DVT. Our findings suggest that the introduction of thromboprophylactic measures, in addition to changes in hospital practice, may have had a highly significant effect on the pattern of this serious, but potentially avoidable disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9119284     DOI: 10.1159/000217189

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  17 in total

Review 1.  Acp. Best practice no 155. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures.

Authors:  R D Start; S S Cross
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Fatal pulmonary embolism in hospitalised patients: a necropsy review.

Authors:  R Alikhan; F Peters; R Wilmott; A T Cohen
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

3.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

4.  Mortality from pulmonary embolism is decreasing in hospital patients.

Authors:  Douglas Kopcke; Ondina Harryman; Emyr W Benbow; Charles Hay; Nicholas Chalmers
Journal:  J R Soc Med       Date:  2011-08       Impact factor: 5.344

5.  Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists' intervention study.

Authors:  Hossein Khalili; Simin Dashti-Khavidaki; Azita Hajhossein Talasaz; Laleh Mahmoudi; Kaveh Eslami; Hamed Tabeefar
Journal:  Pharm World Sci       Date:  2010-07-13

Review 6.  Prevention of venous thromboembolism in medically ill patients: a clinical update.

Authors:  Alexander G G Turpie; Alain Leizorovicz
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

7.  Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Authors:  Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Alexander G G Turpie; Peter Wildgoose; Roger D Yusen
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

Review 8.  Prophylaxis for venous thromboembolism: guidelines translated for the clinician.

Authors:  Gregg Stashenko; Renato D Lopes; David Garcia; John H Alexander; Victor F Tapson
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 9.  Prevention of venous thromboembolism in medical patients and outpatients.

Authors:  Gregg J Stashenko; Victor F Tapson
Journal:  Nat Rev Cardiol       Date:  2009-05       Impact factor: 32.419

Review 10.  Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).

Authors:  Raza Alikhan; Rachel Bedenis; Alexander T Cohen
Journal:  Cochrane Database Syst Rev       Date:  2014-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.